Fierce Biotech December 1, 2023
Conor Hale

Potrero Medical, the company seeking to digitize one of the last remaining undigitized vital signs by actively measuring renal output and predicting acute kidney injuries, has filed for Chapter 11 bankruptcy.

The former Fierce Medtech Fierce 15 winner announced it has begun to voluntarily restructure its equity through pre-negotiated terms filed in Delaware bankruptcy court. The California-based developer said it expects the process to be completed under an expedited schedule that will wrap up before February of next year.

Those proposed bankruptcy terms also provide for Portero to emerge from Chapter 11 with up to $10 million in new financing to help support its plans to continue operations, pending the final determination by the court, according to filings.

Potrero’s Accuryn...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Medical Devices
What tariffs mean for the medical device industry - and who will pay for them?
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns
Labcorp to buy Opko unit’s cancer test assets for up to $225M
Qualcomm CEO: AI Is the New User Interface for Devices
FTC sues to block merger of device coatings companies

Share This Article